Table 2 Clinical characteristics of the study population

study population

 cases

[% (n/total)]

23.9 (38/159)

76.1 (121/159)

100 (159/159)

n.a.

 female

[% (n/total)]

36.8 (14/38)

44.6 (54/121)

42.8 (68/159)

0.397

 male

[% (n/total)]

63.2 (24/38)

55.4 (67/121)

57.2 (91/159)

 age [years]

[mean ± SD]

45.9 ± 10.1

56.3 ± 21.5

53.8 ± 19.9

< 0.001

Goldmann-Witmer coefficient ≥ 2

 Rubella

[% (n/total)]

100 (38/38)

0.8 (1/121)

24.5 (39/159)

< 0.001

 VZV

[% (n/total)]

0 (0/38)

8.26 (10/121)

6.3 (10/159)

0.067

 HSV

[% (n/total)]

0 (0/38)

6.6 (8/121)

5 (8/159)

0.129

 CMV

[% (n/total)]

0 (0/38)

2.5 (3/121)

1.9 (3/159)

0.327

 Toxoplasma

[% (n/total)]

0 (0/38)

4.1 (5/121)

3.1 (5/159)

0.256

clinical presentation

 uveitis

  anterior

[% (n/total)]

100 (38/38)

28.1 (34/121)

45.3 (72/159)

< 0.001

  intermediate

[% (n/total)]

18.4 (7/38)

11.6 (14/121)

13.2 (21/159)

0.277

  posterior

[% (n/total)]

2.6 (1/38)

25.6 (31/121)

20.1 (32/159)

0.002

  panuveits

[% (n/total)]

0 (0/38)

19 (23/121)

14.5 (23/159)

0.004

 cataract

[% (n/total)]

63.2 (24/38)

12.4 (15/121)

24.5 (39/159)

< 0.001

 glaucoma

[% (n/total)]

36.8 (14/38)

18.2 (22/121)

22.6 (36/159)

0.016

 other

[% (n/total)]

7.9 (3/38)

36.4 (44/121)

29.6 (47/159)

< 0.001

localization

 monocular

[% (n/total)]

94.7 (36/38)

66.9 (81/121)

73.6 (117/159)

< 0.001

 binocular

[% (n/total)]

5.3 (2/38)

33.1 (40/121)

26.4 (42/159)